VATE earnings analysis
What we found in VATE's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
INNOVATE Corp. reported a substantial revenue increase of $90.6 million year-over-year in Q1 2026, reaching $364.8 million, primarily driven by their Infrastructure segment. Although the EPS loss narrowed to -$0.58 from -$0.71 in the previous quarter, management highlighted ongoing challenges, particularly in the Life Sciences and Spectrum segments. The company continues to navigate a complex debt landscape and initiate strategic asset sales to improve liquidity.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Growth of $90.6 Million
- Total revenue increased to $364.8 million in Q1 2026, up from $274.2 million a year ago.
- Infrastructure Segment Success
- The Infrastructure segment revenue rose by $93 million to $357.9 million, largely due to heightened project activity.
- Narrowed EPS Loss
- EPS loss improved to -$0.58, compared to -$0.71 from the prior quarter.
- Significant Cash Flow Improvement
- Operating cash flow surged to $45.5 million from a cash outflow of $14.1 million year-over-year.
- Reduced Losses from Equity Investees
- Loss from equity investees decreased to $0 from $5.9 million in the previous year.
- Adjusted EBITDA Surge
- Adjusted EBITDA more than doubled to $19.7 million compared to $7.2 million in Q1 2025.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Going Concern Doubts
- Management noted substantial doubt about the company's ability to continue as a going concern.
- Increased Debt Obligations
- Total consolidated debt rose to $699.0 million, up from $687.2 million, raising liquidity concerns.
- Compliance with Debt Covenants
- Risk of default due to failure to meet milestone requirements under the 10.50% Senior Secured Notes.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.58
- Segment
- Infrastructure: $357.9M
- Segment
- Life Sciences: $1.6M
- Segment
- Spectrum: $5.3M
What they said about what is next.
Guidance expectations deferred to future earnings announcements.
The filing reads better than the one before it.
What came before.
- 10-K · March 26, 2026
- INNOVATE reported a strong Q4 2025 revenue rebound to $383.0M (vs $237.0M in Q4 2024), driving FY2025 revenue of approximately $1,246.0M (vs ~$1,107.0M in FY2024). Management has commenced sales processes for the…
- 10-Q · August 5, 2025
- INNOVATE Corp. reported Q2 revenue of $242.0 million and GAAP diluted EPS of $(1.67). Revenue, gross profit and operating income all declined versus the prior-year quarter, while management discloses substantial doubt…
- 10-Q · August 7, 2024
- INNOVATE Corp. reported Q2 revenue of $313.1M, down $55.7M vs. Q2 2023 ($368.8M) but roughly flat sequentially. Gross profit improved to $65.6M (≈21.0% of revenue) from $52.6M (≈14.3%) in the prior year quarter, driving…
- 10-K · March 6, 2024
- The 10-K positions INNOVATE as a diversified holding company focused on three operating platforms — Infrastructure, Life Sciences and Spectrum — and highlights DBM Global (Infrastructure) as a scale business with…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing VATE makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever